BRPI0820861A2 - Comprimido oral dispersível - Google Patents

Comprimido oral dispersível

Info

Publication number
BRPI0820861A2
BRPI0820861A2 BRPI0820861-1A BRPI0820861A BRPI0820861A2 BR PI0820861 A2 BRPI0820861 A2 BR PI0820861A2 BR PI0820861 A BRPI0820861 A BR PI0820861A BR PI0820861 A2 BRPI0820861 A2 BR PI0820861A2
Authority
BR
Brazil
Prior art keywords
oral tablet
dispersible oral
dispersible
tablet
oral
Prior art date
Application number
BRPI0820861-1A
Other languages
English (en)
Portuguese (pt)
Inventor
Tobias Laich
Thomas Steenpass
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of BRPI0820861A2 publication Critical patent/BRPI0820861A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0820861-1A 2007-12-08 2008-11-25 Comprimido oral dispersível BRPI0820861A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07023802 2007-12-08
PCT/EP2008/009968 WO2009071219A2 (en) 2007-12-08 2008-11-25 Oral dispersable tablet

Publications (1)

Publication Number Publication Date
BRPI0820861A2 true BRPI0820861A2 (pt) 2015-06-16

Family

ID=40631079

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0820861-1A BRPI0820861A2 (pt) 2007-12-08 2008-11-25 Comprimido oral dispersível

Country Status (9)

Country Link
EP (1) EP2231126A2 (de)
JP (2) JP2011506279A (de)
KR (1) KR20100096140A (de)
CN (1) CN101888834A (de)
BR (1) BRPI0820861A2 (de)
MX (1) MX2010005175A (de)
RU (1) RU2010128019A (de)
TW (1) TW200938233A (de)
WO (1) WO2009071219A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010293637B2 (en) * 2009-09-08 2015-12-03 Kyowa Chemical Industry Co., Ltd. Antacid and laxative tablet
CN101797236B (zh) * 2010-03-23 2012-05-23 西南大学 重酒石酸卡巴拉汀口腔崩解片及其制备方法
SI2563329T1 (sl) * 2010-04-27 2017-05-31 Bayer Intellectual Property Gmbh Oralno razgradljiva tableta, ki vsebuje akarbozo
US20110300216A1 (en) * 2010-06-03 2011-12-08 First Eric R Chewable, swallowable and effervescent solid dosage form for oral delivery of pharmaceutical actives
JP5750856B2 (ja) * 2010-10-04 2015-07-22 ライオン株式会社 固形医薬組成物及び医薬製剤
KR101237646B1 (ko) * 2010-12-09 2013-03-04 주식회사 드림파마 생체이용률이 개선된 셀레콕시브 함유 고체 분산체, 이를 포함하는 약학 조성물 및 이의 제조방법
FR2968995B1 (fr) * 2010-12-16 2013-03-22 Sanofi Aventis Composition pharmaceutioue pour une administration par voie orale destinee a eviter le mesusage
FR2968992B1 (fr) * 2010-12-16 2013-02-08 Sanofi Aventis Comprime pharmaceutique orodispersible a base de zolpidem
TR201100150A2 (tr) * 2011-01-06 2012-07-23 Bi̇lgi̇ç Mahmut Suda çözünür dozaj formları
WO2013115741A1 (en) * 2012-01-31 2013-08-08 Mahmut Bilgic Pharmaceutical compositions comprising alpha-glucosidase inhibitor
CN102600149B (zh) * 2012-02-02 2013-12-04 西藏易明西雅生物医药科技有限公司 一种治疗糖尿病的药物组合物
EP3023109A4 (de) 2013-07-19 2017-01-04 Sanwa Kagaku Kenkyusho Co., Ltd Schmelztablette
JP6506752B2 (ja) * 2013-07-19 2019-04-24 バイエル ファーマ アクチエンゲゼルシャフト Ａｐｉミグリトールのための超速崩壊錠剤処方
CN103877041B (zh) * 2014-03-14 2016-07-06 崔书豪 一种吡罗昔康分散片及其制备方法
CN108601798A (zh) * 2016-01-29 2018-09-28 小林光 固体制剂、固体制剂的制备方法及析氢方法
CN105640954B (zh) * 2016-02-04 2019-03-05 青岛市海慈医疗集团 一种治疗消化不良的西沙必利片剂
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN107595788B (zh) * 2016-07-11 2020-08-21 武汉朗来科技发展有限公司 一种用于口服固体制剂的复合崩解剂体系及含有该复合崩解剂体系的口服固体制剂
WO2018037819A1 (ja) 2016-08-23 2018-03-01 小林　光 配合物及びその製造方法、並びに水素供給方法
WO2018037818A1 (ja) 2016-08-23 2018-03-01 小林　光 水素供給材及びその製造方法、並びに水素供給方法
CN107334742B (zh) * 2017-08-18 2020-01-31 山东力诺制药有限公司 一种盐酸氟西汀分散片及其制备方法
MX2020001760A (es) * 2017-09-28 2020-07-29 Hanmi Pharm Ind Co Ltd Composicion farmaceutica que incluye un comprimido esferoide de multiples unidades que contiene esomeprazol y una sal farmaceuticamente aceptable esferoide de este, y metodo para preparar la composicion farmaceutica.
CN110840850B (zh) * 2018-07-24 2023-03-17 烟台药物研究所 一种高生物利用度的塞来昔布冻干口崩片及其制备方法
CN109864971B (zh) * 2019-04-08 2021-12-17 西安远大德天药业股份有限公司 一种拉莫三嗪固体分散体的颗粒剂及其制备方法
CN114224855B (zh) * 2021-12-01 2023-11-28 北京悦康科创医药科技股份有限公司 一种甲磺酸多沙唑嗪口含片及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19802700A1 (de) * 1998-01-24 1999-07-29 Bayer Ag Verfahren zur Herstellung einer im Mund schnell zerfallenden Arzneiform, die als Wirkstoff Acarbose enthält
KR20040079967A (ko) * 2002-02-01 2004-09-16 화이자 프로덕츠 인크. 고체 약물 분산액을 함유하는 속방형 제형
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
EP1620075B1 (de) * 2003-05-07 2020-06-24 Samyang Biopharmaceuticals Corporation Hochplastische granulate zur herstellung von schnell schmelzenden tabletten
US7230016B2 (en) * 2003-05-13 2007-06-12 Synthon Ip Inc. Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
US20070196477A1 (en) * 2004-04-30 2007-08-23 Withiam Michael C Rapidly dissolving tablets comprising low surface area calcium phosphates
US20070196474A1 (en) * 2004-04-30 2007-08-23 Withiam Michael C Rapidly disintegrating low friability tablets comprising calcium carbonate
GB0423103D0 (en) * 2004-10-19 2004-11-17 Boots Healthcare Int Ltd Therapeutic agents

Also Published As

Publication number Publication date
JP2011506279A (ja) 2011-03-03
KR20100096140A (ko) 2010-09-01
TW200938233A (en) 2009-09-16
RU2010128019A (ru) 2012-01-20
JP2015038123A (ja) 2015-02-26
EP2231126A2 (de) 2010-09-29
WO2009071219A3 (en) 2009-09-11
CN101888834A (zh) 2010-11-17
WO2009071219A2 (en) 2009-06-11
MX2010005175A (es) 2010-08-02

Similar Documents

Publication Publication Date Title
BRPI0820861A2 (pt) Comprimido oral dispersível
LTC2498758I2 (lt) Dvisluoksnės tabletės formuluotės
BRPI0808889A2 (pt) Comprimido desintegrante oral
DK3090730T3 (da) Tabletter omfattende eltrombopag-olamin
DK2077729T3 (da) Orale probiotiske doseringsformer
BRPI0820381A2 (pt) Formulações farmacêuticas
DE602007010442D1 (de) Dispergierbare feuchttücher
BRPI0812350A2 (pt) Conexão
DE602008006310D1 (de) Endoskopischer Reprozessor
DK2155586T3 (da) Kapsel til dispergible materialer
BRPI0920521A2 (pt) combinação farmacêutica
ES2981696T3 (es) Chupete
BRPI0819231A2 (pt) Forma de dosagem de desintegração oral
BRPI0908114A2 (pt) tabuleta oral de liberação controlada
BRPI0814188A2 (pt) Formulações
BRPI0812916A2 (pt) Chupeta
EP2133092A4 (de) Oraler impfstoff
GB0710439D0 (en) Oral dosage form
BRPI0821735A2 (pt) Fabricação de tablete
DK2194959T3 (da) Skummedygtig mundplejetilberedning
EP2145884A4 (de) Indoledionderivat
DK2176002T3 (da) Cyklonapparat
BRPI0814835A2 (pt) Composição farmacêutica oral de desmopressina
SE0702098L (sv) Hållaranordning
AT504425B8 (de) Portioniersteuerung

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.